Sök artiklar i SveMed+

Observera: SveMed+ upphör att uppdateras!



Et kollagen XVIII-fragment hemmer angiogenese
Engelsk titel: A fragment of collagen XVIII inhibits angiogenesis Läs online Författare: Zätterström UK ; Fukai N ; Olsen BR Språk: Nor Antal referenser: 21 Dokumenttyp: Översikt UI-nummer: 00122416

Tidskrift

Tidsskrift for Den Norske Laegeforening 2000;120(29)3547-50 ISSN 0029-2001 E-ISSN 0807-7096 KIBs bestånd av denna tidskrift Denna tidskrift är expertgranskad (Peer-Reviewed)

Sammanfattning

BACKGROUND : Malignant tumours may produce substances with both stimulatory and inhibitory effect on angiogenesis. MATERIAL AND METHODS : A protein fragment with angiogenesis-inhibiting potential was recently identified in conditioned media from a murine endothelial tumour cell line. RESULTS : The angiogenesis inhibitor, endostatin, is a 20 kDa C-terminal fragment of collagen XVIII, a proteoglycan/collagen found in vessel walls and basement membranes. The generation of endostatin or endostatin-like collagen XVIII fragments is catalyzed by proteolytic enzymes, including cathepsin L and matrix metalloproteases, that cleave peptide bonds within the protease-sensitive hinge region of the C-terminal domain. INTERPRETATION : The physiological processing of collagen XVIII to endostatin may represent a local control mechanism for the regulation of angiogenesis. The outcome of ongoing clinical trials will determine the role of endostatin as a possible angiogenesis-inhibiting drug in the future.